Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 10/20 | 0.65 |
| ▸ | BCHE | P06276 | 2/20 | 0.65 |
| ▸ | ACHE | P22303 | 2/20 | 0.65 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 6/20 | 0.42 |
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.40 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.40 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29499615 | 0.88 | MAOA (0.49) | NOX1BCHEACHEMAOAMAOB | |
| SCHEMBL27581232 | 0.88 | MAOA (0.49) | NOX1BCHEACHEMAOAMAOB | |
| SCHEMBL28117917 | 0.88 | NOX1 (0.76) | NOX1BCHEACHEMAOAGAA | |
| SCHEMBL8941074 | 0.84 | MAOA (0.55) | NOX1BCHEACHEMAOAMAOB | |
| SCHEMBL28117966 | 0.84 | NOX1 (0.81) | NOX1BCHEACHEMAOAGAA | |
| SCHEMBL1855994 | 0.83 | NOX1 (0.65) | NOX1BCHEACHEGAAMAPT | |
| SCHEMBL11539366 | 0.80 | NOX1 (0.65) | NOX1BCHEACHEMAOAGAA | |
| SCHEMBL28635096 | 0.80 | NOX1 (0.65) | NOX1BCHEACHEMAOAGAA | |
| SCHEMBL7673182 | 0.80 | NOX1 (0.62) | NOX1BCHEACHEMAOAGAA | |
| SCHEMBL30697368 | 0.80 | NOX1 (0.62) | NOX1BCHEACHEMAOAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12502661-B2 | Catalysts for synthesizing cyclic carbonates, preparation methods and uses thereof | ANHUI CONCH MATERIAL TECHNOLOGY CO., LTD. (CN) | 2025-12-23 | — | — | US | disclosed |
| US-20250352989-A1 | CATALYSTS FOR SYNTHESIZING CYCLIC CARBONATES, PREPARATION METHODS AND USES THEREOF | ANHUI CONCH MATERIAL TECH CO LTD (CN) | 2025-11-20 | — | — | US | disclosed |
| CN-118179610-B | Catalyst for synthesizing cyclic carbonate, preparation method and application thereof | 安徽海螺材料科技股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118179610-A | Catalyst for synthesizing cyclic carbonate, preparation method and application thereof | 安徽海螺材料科技股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352989-A1 | CATALYSTS FOR SYNTHESIZING CYCLIC CARBONATES, PREPARATION METHODS AND USES THEREOF | PBRM1, POLL, PPOX | NOX1 2100/4885BCHE 4170/4885ACHE 3090/4885 |
| US-12502661-B2 | Catalysts for synthesizing cyclic carbonates, preparation methods and uses thereof | PBRM1, POLL, PPOX | NOX1 2100/4885BCHE 4170/4885ACHE 3090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.